Autolus Therapeutics plc (AUTL)

NASDAQ: AUTL · Real-Time Price · USD

1.560

+0.010 (0.65%)

At close: Nov 3, 2025, 4:00 PM EST

1.560

0.00 (0.00%)

After-hours: Nov 3, 2025, 4:10 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2014 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2014 - 2019
Chimeric Antigen Receptors T Cell Therapies	10.12M	Log In	Log In	Log In	Log In	Upgrade
Chimeric Antigen Receptors T Cell Therapies Growth	496.00%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2014 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2014 - 2019
Europe	10.12M	Log In	Log In	Log In	Log In	Upgrade
United States	-	Log In	Log In	Log In	Log In	Upgrade
United Kingdom	-	Log In	Log In	Log In	Log In	Upgrade
United Kingdom, Europe and United States	-	Log In	Log In	Log In	Log In	Upgrade
United Kingdom, Europe and United States Growth	-	Log In	Log In	Log In	Log In	Upgrade